Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Vedroprevir

Generic Name: Vedroprevir

Drug Type: Small Molecule

Chemical Formula: C_₄₅H_₆₀ClN_₇O_₉S

CAS Number: 1098189-15-1

Unique Ingredient Identifier: KGD958X2B9

Overview

Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.

Background

Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis

Phase 2

Completed

Posted: 2014/08/27

Sponsor:Gilead Sciences

ID:NCT02226549

Combination Therapy for Chronic Hepatitis C Infection

Phase 2

Completed

Posted: 2013/03/06

Sponsor:National Institute o...

ID:NCT01805882

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Phase 2

Completed

Posted: 2011/09/16

Sponsor:Gilead Sciences

ID:NCT01435226

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

Phase 2

Terminated

Posted: 2011/06/29

Sponsor:Gilead Sciences

ID:NCT01384383

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

Phase 2

Completed

Posted: 2011/05/19

Sponsor:Gilead Sciences

ID:NCT01356160

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy